Dengue tetravalent vaccine, live

Brand Name

Dengvaxia3437

Pharmacological Class

Vaccine for active immunization (as a three-shot series to protect against dengue disease caused by infection with virus serotypes 1–4 in children 9–16 years of age living in endemic areas and having a laboratory-confirmed previous infection)

Use

Prophylaxis against dengue fever

Monograph
Further Reading in Goodman & Gilman